Format

Send to

Choose Destination
Eur Heart J. 2016 Jun 14;37(23):1850-8. doi: 10.1093/eurheartj/ehv727. Epub 2016 Jan 19.

Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases.

Author information

1
Departments of Cardiology and Experimental Cardiology, Academic Medical Hospital (AMC) at the University of Amsterdam, Amsterdam, The Netherlands y.pinto@amc.uva.nl.
2
Inherited Cardiac Diseases Unit, The Heart Hospital, University College London, London, UK.
3
Center for Inherited Cardiovascular Diseases, IRCCS Foundation Policlinico San Matteo, Pavia, Italy.
4
Management, The Chaim Sheba Medical Center, Tel Hashomer, The Sackler School of Medicine Tel Aviv University, Tel Aviv, Israel.
5
First Cardiology Department, University of Athens, Medical School, Athens, Greece.
6
Klinik für Innere Medizin III, Universitätsklinikum des Saarlandes, Homburg, Germany.
7
Assistance Publique Hôpitaux de Paris (AP HP), Hôpital Cochin, Université Paris Descartes, Paris, France.
8
Department of Cardiology, University Hospital Virgen de Arrixaca, Murcia, Spain.
9
Service de cardiologie, Pôle cardio-vasculaire et Pulmonaire, CHRU de Lille, Lille, France Inserm U1167, Institut Pasteur de Lille, Université de Lille 2, Lille, France.
10
Cardiology Department, Maria Vittoria Hospital and University of Torino, Torino, Italia.
11
Cardiovascular Research Institute Maastricht, Department of Cardiology, Maastricht University Medical Center, Maastricht, Netherlands ICIN, Netherlands Heart Institute, Utrecht, Netherlands.
12
Department of Molecular Pathology, Institute for Pathology, University Hospital Tübingen, Tübingen, Germany.
13
INSERM UMRS-956, UPMC Univ Paris 6, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France.
14
Division of Cardiology, Monaldi Hospital, Second University of Naples, Naples, Italy.
15
Second Department of Medicine, Department of Cardiovascular Medicine, General University Hospital and the First Faculty of Medicine, Charles University, Prague, Czech Republic.
16
Department of Cardiology, Odense University Hospital, Odense, Denmark.
17
Division of Cardiovascular Imaging and Biostatistics, The Heart Hospital, London, UK.
18
Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
19
Department of Cardiology, University Medical Center, Belgrade, Serbia.
20
Department of Cardiology, Freeman Hospital, Newcastle upon Tyne, UK.
21
Cardiac Imaging Unit, Ramón y Cajal University Hospital, Madrid, Spain.
22
Division of Cardiology, Department of Cardiological Thoracic and Vascular Sciences, University of Padova, Padova, Italy.
23
Université de Versailles-Saint Quentin, Hôpital Ambroise Paré, AP-HP, Boulogne-Billancourt, France AP-HP, Hôpital Pitié-Salpêtrière, Paris, France.

Abstract

In this paper the Working Group on Myocardial and Pericardial Disease proposes a revised definition of dilated cardiomyopathy (DCM) in an attempt to bridge the gap between our recent understanding of the disease spectrum and its clinical presentation in relatives, which is key for early diagnosis and the institution of potential preventative measures. We also provide practical hints to identify subsets of the DCM syndrome where aetiology directed management has great clinical relevance.

KEYWORDS:

Dilated cardiomyopathy; Heart failure; Position statement

PMID:
26792875
DOI:
10.1093/eurheartj/ehv727
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center